These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1814396)
1. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease. Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease. Inaguma Y; Shinohara H; Inagaki T; Kato K J Neurol Sci; 1992 Jul; 110(1-2):57-61. PubMed ID: 1506869 [TBL] [Abstract][Full Text] [Related]
3. [Aging of nervous system and S-100 proteins]. Kato K; Asano T; Inagaki T; Yamamoto T; Sato T Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):287-92. PubMed ID: 2145454 [TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197 [TBL] [Abstract][Full Text] [Related]
5. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease]. Bons N; Mestre N C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922 [TBL] [Abstract][Full Text] [Related]
6. Selective increase in S-100 beta protein by aging in rat cerebral cortex. Kato K; Suzuki F; Morishita R; Asano T; Sato T J Neurochem; 1990 Apr; 54(4):1269-74. PubMed ID: 2107276 [TBL] [Abstract][Full Text] [Related]
7. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software]. Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271 [TBL] [Abstract][Full Text] [Related]
8. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661 [TBL] [Abstract][Full Text] [Related]
9. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease. Sorbi S; Piacentini S; Amaducci L Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. Hof PR; Cox K; Morrison JH J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598 [TBL] [Abstract][Full Text] [Related]
12. Alterations in Alzheimer's disease-associated protein in Alzheimer's disease frontal and temporal cortex. Bissette G; Smith WH; Dole KC; Crain B; Ghanbari H; Miller B; Nemeroff CB Arch Gen Psychiatry; 1991 Nov; 48(11):1009-12. PubMed ID: 1747015 [TBL] [Abstract][Full Text] [Related]
13. Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease. Davidsson P; Bogdanovic N; Lannfelt L; Blennow K Dement Geriatr Cogn Disord; 2001; 12(4):243-50. PubMed ID: 11351135 [TBL] [Abstract][Full Text] [Related]
14. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Yew DT; Wong HW; Li WP; Lai HW; Yu WH Neuroscience; 1999 Mar; 89(3):675-86. PubMed ID: 10199604 [TBL] [Abstract][Full Text] [Related]
16. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Hellweg R; Gericke CA; Jendroska K; Hartung HD; Cervós-Navarro J Int J Dev Neurosci; 1998; 16(7-8):787-94. PubMed ID: 10198825 [TBL] [Abstract][Full Text] [Related]
17. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828 [TBL] [Abstract][Full Text] [Related]
18. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Dedman DJ; Treffry A; Candy JM; Taylor GA; Morris CM; Bloxham CA; Perry RH; Edwardson JA; Harrison PM Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):509-14. PubMed ID: 1445209 [TBL] [Abstract][Full Text] [Related]
19. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745 [TBL] [Abstract][Full Text] [Related]
20. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Norris PJ; Faull RL; Emson PC Brain Res Mol Brain Res; 1996 Sep; 41(1-2):36-49. PubMed ID: 8883932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]